Guiding Fluid Resuscitation in Septic Shock: Ultrasound vs. Noninvasive Cardiac Output Monitoring
CUS-NICOM-SS
The Value of Critical Care Ultrasound and Noninvasive Cardiac Output Monitoring in Guiding Fluid Resuscitation for Septic Shock in the Emergency Department
2 other identifiers
interventional
60
1 country
1
Brief Summary
This randomized controlled study investigates the value of critical care ultrasound and non-invasive cardiac output monitoring in guiding fluid resuscitation for patients with septic shock in the emergency department. A total of 60 patients are randomly assigned to receive either ultrasound-guided or NICOM-guided fluid management, with both groups receiving standard sepsis care according to the 2021 Surviving Sepsis Campaign guidelines. The study aims to evaluate whether these monitoring modalities can optimize hemodynamic management, improve prognosis, and support clinical decision-making in emergency settings. Primary and secondary outcomes include early resuscitation efficacy (time to achieve mean arterial pressure ≥65 mmHg and lactate clearance), total fluid volume within the first 6 hours, incidence of complications (pulmonary edema, renal injury, ARDS), length of stay in the emergency department and hospital, and 28-day mortality. By comparing these two approaches, this study seeks to provide evidence for selecting appropriate monitoring tools to achieve precise and individualized fluid resuscitation in septic shock.
Trial Health
Trial Health Score
Automated assessment based on enrollment pace, timeline, and geographic reach
participants targeted
Target at P25-P50 for not_applicable
Started Jul 2023
Typical duration for not_applicable
1 active site
Health score is calculated from publicly available data and should be used for screening purposes only.
Trial Relationships
Click on a node to explore related trials.
Study Timeline
Key milestones and dates
Study Start
First participant enrolled
July 5, 2023
CompletedPrimary Completion
Last participant's last visit for primary outcome
July 31, 2025
CompletedStudy Completion
Last participant's last visit for all outcomes
July 31, 2025
CompletedFirst Submitted
Initial submission to the registry
August 16, 2025
CompletedFirst Posted
Study publicly available on registry
September 9, 2025
CompletedSeptember 22, 2025
September 1, 2025
2.1 years
August 16, 2025
September 16, 2025
Conditions
Keywords
Outcome Measures
Primary Outcomes (2)
28-day mortality rate
Proportion of patients who die within 28 days after enrollment. Mortality will be assessed using hospital records and survival follow-up.
28 days from enrollment
28-Day Survival
Proportion of patients who survive at 28 days after enrollment.
28 days from enrollment
Secondary Outcomes (10)
ICU hospitalization time
From enrollment to the end of treatment at 4 weeks
Use of Mechanical Ventilation
From enrollment to the end of treatment at 4 weeks
Duration of Mechanical Ventilation
From enrollment to the end of treatment at 4 weeks
Use of Vasopressor Therapy
From enrollment to the end of treatment at 4 weeks
Time to Achieve Mean Arterial Pressure ≥65 mmHg
Within the first 6 hours after enrollment
- +5 more secondary outcomes
Study Arms (2)
Critical Care Ultrasound Group
EXPERIMENTALpatients underwent immediate bedside assessment using a Philips EPIQ 5 color Doppler ultrasound system equipped with both phased-array (1.5-4.0 MHz) and convex-array (2.0-5.0 MHz) transducers. The initial ultrasound evaluation was completed within 10 minutes of enrollment and included comprehensive hemodynamic monitoring: inferior vena cava diameter (IVC) and collapsibility index (IVC-CI) for volume status assessment, left ventricular ejection fraction (LVEF) and end-diastolic volume (LVEDV) for cardiac function evaluation, ventricular wall motion analysis, along with pulmonary B-line quantification to assess pulmonary edema.
Non-Invasive Cardiac Output Monitoring (NICOM) Group
EXPERIMENTALIn the noninvasive cardiac output monitoring group, continuous hemodynamic assessment was performed using the NICOM system based on thoracic bioreactance technology.
Interventions
Monitoring commenced immediately after enrollment, with baseline parameters recorded after signal stabilization (≤5 minutes), including cardiac output (CO), stroke volume (SV), stroke volume variation (SVV), and systemic vascular resistance (SVR). The system automatically updated these parameters every 30 seconds and displayed them in real-time on the monitor screen. Fluid resuscitation was dynamically adjusted according to these continuous measurements until achieving the predefined therapeutic targets.
In the critical care ultrasound group, patients underwent immediate bedside This protocol ensured real-time, comprehensive evaluation of both cardiac function and fluid status to guide resuscitation.Ultrasound reassessment was performed every 1-2 hours to dynamically adjust both the volume and rate of fluid administration until predefined resuscitation targets were achieved.
Eligibility Criteria
You may qualify if:
- diagnosis of septic shock in accordance with the Surviving Sepsis Campaign International ;
- receipt of initial fluid resuscitation in the emergency department with a hospital stay of at least 6 hours;
- age ≥ 18 years;
- provision of informed consent.
- Excluded criteria:
- contraindications to rapid fluid administration (e.g., end-stage renal disease, end-stage heart failure, acute pulmonary edema);
- inability to comply with treatment, such as patients with severe trauma, burns, cancer undergoing chemotherapy, pregnant or lactating women, and those with mental illness;
- withdrawal from treatment or transfer to another facility within 24 hours of admission.
Contact the study team to confirm eligibility.
Sponsors & Collaborators
- Mai Xiaoweilead
- Guangzhou Panyu Central Hospitalcollaborator
Study Sites (1)
Panyu Central Hospital Affiliated to Guangzhou Medical University
Guangzhou, Guangdong, 510000, China
MeSH Terms
Conditions
Condition Hierarchy (Ancestors)
Study Officials
- PRINCIPAL INVESTIGATOR
yingshen wen
Guangzhou Panyu Central Hospital, Guangzhou, Guangdong , China
Study Design
- Study Type
- interventional
- Phase
- not applicable
- Allocation
- RANDOMIZED
- Masking
- SINGLE
- Who Masked
- PARTICIPANT
- Purpose
- TREATMENT
- Intervention Model
- PARALLEL
- Sponsor Type
- OTHER
- Responsible Party
- SPONSOR INVESTIGATOR
- PI Title
- Emergency Department Attending Physician,Guangzhou Panyu Central Hospital
Study Record Dates
First Submitted
August 16, 2025
First Posted
September 9, 2025
Study Start
July 5, 2023
Primary Completion
July 31, 2025
Study Completion
July 31, 2025
Last Updated
September 22, 2025
Record last verified: 2025-09